This announcement is a separate document:
Neurotech International Ltd: Further clinical benefit at 52 weeks in PANDAS/PANS patients
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.